Balance Sheet

Accounts Payables Accumulated Expenses Assets Buildings Capital Leases Cash & Current Investments Cash & Equivalents Common Equity Construction in Progress Current Assets Current Deferred Revenue Current Deferred Tax Assets Current Leases Current Taxes Finished Goods Goodwill Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Liabilities from Discontinued Operations Long-Term Deferred Tax Minority Interest Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Non-Current Deffered Revenue Operating Leases Other Non-Current Assets Other Non-Current Liabilities Payables Preferred Shares Prepaid Assets Property, Plant & Equipment (Net)Raw Materials Receivables Retained Earnings Shareholder's Equity Shares Outstanding Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares

Daily Values

Growth Metrics

Others

Apyx Medical (APYX) Short term Debt (2016 - 2023)

Apyx Medical's Short term Debt history spans 12 years, with the latest figure at $8.9 million for Q2 2023.

For Q2 2023, Short term Debt changed N/A year-over-year to $8.9 million; the TTM value through Jun 2023 reached $8.9 million, changed N/A, while the annual FY2019 figure was $140000.0, N/A changed from the prior year.
Short term Debt reached $8.9 million in Q2 2023 per APYX's latest filing, up from $8.8 million in the prior quarter.
In the past five years, Short term Debt ranged from a high of $8.9 million in Q2 2023 to a low of $140000.0 in Q4 2019.
Average Short term Debt over 3 years is $3.0 million, with a median of $140000.0 recorded in 2019.